Digital Rectal Exam and Prostate Cancer Screening
1. Identify patients within the screening arm of the PLCO trial who were found to have a suspicious DRE on exam at any screening encounter during the trial period.
2. Primary Objective and Outcome: Compare the prostate cancer-specific survival of those with suspicious vs non-suspicious DRE.
3. Secondary Objectives and Outcomes: Compare rates of cancer detection and high grade cancer between the two groups.
Dr. Karla Ballman, Chief of Biostatistics and Epidemiology, Weill Cornell Medical College
Dr. Jim Hu, Professor of Urology, Weill Cornell Medical College
-
Use of Digital Rectal Examination as an Adjunct to Prostate Specific Antigen in the Detection of Clinically Significant Prostate Cancer.
Halpern JA, Oromendia C, Shoag JE, Mittal S, Cosiano MF, Ballman KV, Vickers AJ, Hu JC
J. Urol. 2017 Oct PUBMED